loader
Please Wait
Applying Filters...

Annual Sales of CAS-58-46-8 reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 7,508Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Xenazine

02 3Xenazine?

PharmaCompass

01

Brand Name : Xenazine?

Tetrabenazine

arrow
Discovery on Target
Not Confirmed

Brand Name : Xenazine?

arrow
Discovery on Target
Not Confirmed

Tetrabenazine

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 29

2019 Revenue in Millions : 38

Growth (%) : -24

blank

02

Brand Name : Xenazine?

Tetrabenazine

arrow
Discovery on Target
Not Confirmed

Brand Name : Xenazine?

arrow
Discovery on Target
Not Confirmed

Tetrabenazine

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 22

2020 Revenue in Millions : 29

Growth (%) : -24

blank

03

Brand Name : Xenazine?

Tetrabenazine

arrow
Discovery on Target
Not Confirmed

Brand Name : Xenazine?

arrow
Discovery on Target
Not Confirmed

Tetrabenazine

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 38

2018 Revenue in Millions : 52

Growth (%) : -27

blank

04

Brand Name : Xenazine

Tetrabenazine

arrow
Luxepack
Not Confirmed

Brand Name : Xenazine

arrow
Luxepack
Not Confirmed

Tetrabenazine

Main Therapeutic Indication : Rare Disease

Currency : USD

2015 Revenue in Millions : 254

2014 Revenue in Millions : 330

Growth (%) : 30%

blank

05

Brand Name : Xenazine

Tetrabenazine

arrow
Discovery on Target
Not Confirmed

Brand Name : Xenazine

arrow
Discovery on Target
Not Confirmed

Tetrabenazine

Main Therapeutic Indication : Rare Disease

Currency : USD

2014 Revenue in Millions : 19%

2013 Revenue in Millions :

Growth (%) :

blank

06

Brand Name : Xenazine

Tetrabenazine

arrow
Discovery on Target
Not Confirmed

Brand Name : Xenazine

arrow
Discovery on Target
Not Confirmed

Tetrabenazine

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 178

2016 Revenue in Millions : 267

Growth (%) : -33

blank

07

Brand Name : Xenazine

Tetrabenazine

arrow
Discovery on Target
Not Confirmed

Brand Name : Xenazine

arrow
Discovery on Target
Not Confirmed

Tetrabenazine

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 66

2017 Revenue in Millions : 157

Growth (%) : -58%

blank

08

Brand Name : Xenazine

Tetrabenazine

arrow
Discovery on Target
Not Confirmed

Brand Name : Xenazine

arrow
Discovery on Target
Not Confirmed

Tetrabenazine

Main Therapeutic Indication : Rare Diseases

Currency : USD

2016 Revenue in Millions : 157

2015 Revenue in Millions : 223

Growth (%) : -30

blank

09

Brand Name : Xenazine

Tetrabenazine

arrow
Discovery on Target
Not Confirmed

Brand Name : Xenazine

arrow
Discovery on Target
Not Confirmed

Tetrabenazine

Main Therapeutic Indication : Rare Diseases

Currency : USD

2017 Revenue in Millions : 113

2016 Revenue in Millions : 157

Growth (%) : -28

blank

10

Brand Name : Xenazine

Tetrabenazine

arrow
Discovery on Target
Not Confirmed

Brand Name : Xenazine

arrow
Discovery on Target
Not Confirmed

Tetrabenazine

Main Therapeutic Indication : Rare Diseases

Currency : USD

2018 Revenue in Millions : 52

2017 Revenue in Millions : 122

Growth (%) : -57%

blank